Overview
Matthew Cotant is a Hematologist Oncology specialist and a Hematologist in Port Huron, Michigan. Dr. Cotant and is rated as an Advanced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Neuroendocrine Tumor, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Cotant is currently accepting new patients.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Priority Health
- Blue Cross Blue Shield
- McLaren Health
- UnitedHealthcare
- Humana
Locations
1221 Pine Grove Ave, Port Huron, MI 48060
3601 W 13 Mile Rd, Royal Oak, MI 48073
27900 Grand River Ave, Farmington Hills, MI 48336
28100 Grand River Ave, Farmington Hills, MI 48336
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MediFind cannot find any recent clinical research or clinical trials for Dr. Matthew B. Cotant
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Adult Immune Thrombocytopenia
- Adult Soft Tissue Sarcoma
- Anal Cancer
- Bone Tumor
- Childhood Iron Deficiency Anemia
- Chronic Familial Neutropenia
- Advanced
- Acute Mountain Sickness
- Agranulocytosis
- ALK-Positive Non-Small Cell Lung Cancer
- Anemia
- Autoimmune Hemolytic Anemia
- Bladder Cancer
- Experienced
- Acquired Agranulocytosis
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)
- Alveolar Soft Part Sarcoma
- Ampullary Cancer